APA (7th ed.) Citation

Mihai Miclăuș & Gabriel Balmus. (2024). CRISPR-Cas9-directed gene therapy for spinocerebellar ataxia type 1. Elsevier.

Chicago Style (17th ed.) Citation

Mihai Miclăuș and Gabriel Balmus. CRISPR-Cas9-directed Gene Therapy for Spinocerebellar Ataxia Type 1. Elsevier, 2024.

MLA (9th ed.) Citation

Mihai Miclăuș and Gabriel Balmus. CRISPR-Cas9-directed Gene Therapy for Spinocerebellar Ataxia Type 1. Elsevier, 2024.

Warning: These citations may not always be 100% accurate.